Olinvacimab (TTAC-0001) is a human monoclonal antibody targeting VEGFR-2/KDR with anti-angiogenic activity that blocks tumor angiogenesis and may be used to study solid tumors.
Purity:
97.70%
CAS Number:
[2095504-49-5]
Target:
VEGFR
* VAT and and shipping costs not included. Errors and price changes excepted